morn pg report result sale ep
expect addit pg updat all-in sale guidanc addit
fx headwind expect all-in sale flat vs
previous still expect organ sale growth despit
headwind compani maintain core ep growth guidanc
pleas see attach document thought analysi
result expect morn pg report result includ sale
higher expect ep beat net sale yoy
estim yoy consensu estim yoy
adjust ep consensus-match estim note
recent updat model estim fx headwind compani result would
beaten previou estim well organ sale growth yoy
compani full year target lower-than-expect sg vs estimate
higher sale lower interest expens partial off-set lower-than-expect gross
margin vs estimate lower incom drove ep beat vs
sale guidanc lower fx ep guid unchang pg updat all-in sale
guidanc includ larger headwind fx compani still expect organ sale
growth all-in sale growth expect flat vs previous fx
headwind estim hit total sale growth vs previous despit
chang core ep growth still expect rang equat ep
note reduc ep estim fx earlier week
organ sale growth improv organ net sale yoy volum growth
mix drove increas price flat look segment beauti saw strong organ
growth driven double-digit growth skin person care segment continu benefit
posit mix effect higher end product line well addit market invest
fabric post organ growth volum growth mix partial
off-set price price segment improv last quarter still
yoy compani highlight strengthen merchandis program one sale
driver continu monitor price segment go forward baby/feminine/famili
organ sale declin due declin babi mid valu tier well addit
price invest luv brand groom segment organ sale grew
highest organ growth rate segment sinc shave care organ sale increas msd
compani see lift new innov increas price certain market
partial off-set neg mix lastli health saw organ growth
page
figur organ net sale growth segment
stock due better expect organ growth quarter
maintain ep guidanc year expect stock open morn despit
market concern around recent advers fx move compani abl maintain
core ep guidanc full year ye lower sale growth guidanc fx
believ larg expect organ sale growth outlook unchang
addit quarter expect everi segment except baby/fem/famili
post organ sale growth improv groom particular highlight
come year half declin signific reset strategi
solid quarter pg better expect start cpg earn season
confer call detail compani host confer call et discuss
result dial pass code
figur vs strh estim
page
dollar million except per-shar beauti fabric babi famili compani report strh estim adjust one-tim itemssegmentorgan sale growth total salesbeauti famili compani report strh research procter gambl compani
valuat risk
price target equat ep estim line cpg peer-group averag
upsid risk rate price target includ higher growth profit
china busi accret share repurchas downsid risk rate price
activ core categori signific currenc fluctuat
william chappel jr herebi certifi view express research report accur
reflect person view subject compani secur also certifi
receiv direct indirect compens exchang
express specif recommend report
analyst compens base upon stock price perform qualiti analysi commun skill
overal revenu profit firm includ invest bank revenu
matter polici practic firm prohibit offer favor research specif
research rate specif target price consider induc receipt busi
compens addit associ person prepar research report prohibit own
secur subject compani
strh rate system equiti secur
dissemin research
suntrust robinson humphrey strh seek make reason effort provid research report
simultan elig client report avail publish restrict access area
websit elig client request password institut investor corpor
member press may also receiv research via third parti vendor includ thomson reuter
bloomberg factset capit iq addit distribut may done sale personnel via
email fax electron mean regular mail
access third parti vendor research websit http //suntrustlibrari bluematrix com/client/
pleas email research depart
contact strh sale repres
rate system effect oct
page
strh rate equiti secur
rate rel broader market gener next month unless
buy stock total return expect outperform relev benchmark
hold stock total return expect perform line relev benchmark
next month unless otherwis indic
sell stock total return expect under-perform relev benchmark
next month unless otherwis indic
rate nr strh invest rate opinion stock
coverag suspend cs indic strh rate and/or target price temporarili
suspend due applic regul and/or strh manag discret previous publish
rate target price reli upon
strh analyst price target stock cover unless otherwis indic price
target repres analyst expect stock trade next month unless
otherwis indic analyst believ insuffici valuat driver and/or invest
catalyst deriv posit neg invest view may elect approv strh
research manag assign target price likewis certain stock trade may
exhibit volatil wherebi assign price target would unhelp make invest decis
research manag approv analyst may refrain assign target sub-
legend rate price target histori chart
prior rate system oct
design base total return within period
buy total return low-beta secur
reduc total return neg low beta secur
neutral total return within bound
nr rate strh provid equiti research coverag
total return price appreci dividend price target within period unless
otherwis note beta defin secur averag beta less use bloomberg
suntrust robinson humphrey rate distribut
page
